One department at the University of Texas at San Antonio School of Public Health is focused on understanding the health challenges associated with a changing climate and developing solutions to mitigate or even prevent them.

Is there a connection? Bonnie Petrie talks with a pediatrician who specializes in neurodevelopmental disorders like autism about the president's claims on Tylenol and the MMR vaccine as potential causes of autism and a form of vitamin B9 as a potential treatment.

'Most people think carcinomatosis is a death sentence, but there are different treatment modalities that I offer to patients. And that's something that is pretty unique to UT Health San Antonio,' said Dr. Mio Kitano, a surgical oncologist.

A UT San Antonio Health Science Center researcher has found that people with resilient immune systems can live 15 years longer than those who don't, but what is immune resilience? How do you know if your immune system is lagging? Can you get some of those years back?

A San Antonio researcher is working on a drug that could treat Ewing sarcoma and rhabdomyosarcoma without lifelong side effects. It would be the first new treatment option for these childhood cancers in 30 years.

Malaria kills more than half a million people a year, and an effective vaccine has been elusive. But a San Antonio malaria researcher and her team have discovered a vulnerability in the malaria parasite's method of avoiding the human immune system that may make all the difference.

Petrie Dish host Bonnie Petrie sits down with Public Health Watch reporter Raquel Torres to talk about her story on the Alzheimer's crisis in the Rio Grande Valley, as well as a $3 billion proposal to fund Alzheimer's research in Texas that won't go forward unless Texans say yes at the polls in November.

Prostate cancer is the most common cancer diagnosed in men and the five year survival rate is 97%.

UT Health San Antonio Speech-Language Pathology program graduate students are helping local kids at risk for developing a language disorder through a program called LAUNCH. Angela Kennedy, SLP-D, CCC-SLP, is the director of clinical education and an assistant professor for the Speech-Language Pathology program in the Department of Communication Sciences and Disorders.

An anti-aging medication called rapamycin seems to work better in female mice than in males, and it's the only one studied as part of the National Institute of Aging's Interventions Testing Program to do so. Most of the medications singled out for their effectiveness in a recent review only work in male mice.